- Home
- COCH vs BCAB Comparison
COCH vs BCAB Comparison
Compare COCH & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- BCAB
- Stock Information
- Founded
- COCH 1995
- BCAB 2007
- Country
- COCH United States
- BCAB United States
- Employees
- COCH N/A
- BCAB N/A
- Industry
- COCH Blank Checks
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- COCH Finance
- BCAB Health Care
- Exchange
- COCH Nasdaq
- BCAB Nasdaq
- Market Cap
- COCH N/A
- BCAB 27.0M
- IPO Year
- COCH N/A
- BCAB 2020
- Fundamental
- Price
- COCH $1.37
- BCAB $0.34
- Analyst Decision
- COCH Strong Buy
- BCAB Buy
- Analyst Count
- COCH 3
- BCAB 2
- Target Price
- COCH $8.00
- BCAB $1.00
- AVG Volume (30 Days)
- COCH 18.1K
- BCAB 631.0K
- Earning Date
- COCH 03-31-2025
- BCAB 03-27-2025
- Dividend Yield
- COCH N/A
- BCAB N/A
- EPS Growth
- COCH N/A
- BCAB N/A
- EPS
- COCH N/A
- BCAB N/A
- Revenue
- COCH $225,000.00
- BCAB $11,000,000.00
- Revenue This Year
- COCH $51.11
- BCAB N/A
- Revenue Next Year
- COCH $92.00
- BCAB N/A
- P/E Ratio
- COCH N/A
- BCAB N/A
- Revenue Growth
- COCH N/A
- BCAB N/A
- 52 Week Low
- COCH $1.21
- BCAB $0.24
- 52 Week High
- COCH $7.20
- BCAB $4.02
- Technical
- Relative Strength Index (RSI)
- COCH 46.53
- BCAB 41.83
- Support Level
- COCH $1.39
- BCAB $0.28
- Resistance Level
- COCH $1.46
- BCAB $0.40
- Average True Range (ATR)
- COCH 0.09
- BCAB 0.04
- MACD
- COCH -0.01
- BCAB 0.01
- Stochastic Oscillator
- COCH 42.86
- BCAB 48.29
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.